Major depressive disorder, sleep EEG and agomelatine: an open-label study. (Q48469969)

11 February 2018

title

Major depressive disorder, sleep EEG and agomelatine: an open-label study. (English)

1 reference

11 February 2018

major depressive disorder

1 reference

1 reference

inferred from title

author

Christian Guilleminault

8

object named as

Christian Guilleminault

1 reference

11 February 2018

3

Judith Laredo

1 reference

11 February 2018

author name string

Maria-Antonia Quera Salva

1

1 reference

11 February 2018

Bernard Vanier

2

1 reference

11 February 2018

Sarah Hartley

4

1 reference

11 February 2018

Florian Chapotot

5

1 reference

11 February 2018

Catherine Moulin

6

1 reference

11 February 2018

Frédéric Lofaso

7

1 reference

11 February 2018

publication date

4 May 2007

1 reference

11 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

11 February 2018

volume

10

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

691-696

1 reference

11 February 2018

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Systematic Trends Across the Night in Human Sleep Cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

All-night spectral analysis of the sleep EEG in untreated depressives and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Sleep EEG, depression and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Effects of sertraline on sleep architecture in patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Antidepressants and sleep: a qualitative review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

Effects of trazodone on the sleep of depressed subjects--a polygraphic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

7 January 2021

Heart rate circadian rhythm as a biological marker of desynchronization in major depression: a methodological and preliminary report

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

7 January 2021

Modulation of voltage-dependent Ca2+ conductance by changing Cl- concentration in rat lactotrophs.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007754

7 January 2021

10.1017/S1461145707007754

Identifiers

DOI

0 references

PubMed ID

17477886

1 reference

11 February 2018